MedPath

Contrast sensitivity evaluation of DOT spectacle lenses

Phase 3
Completed
Conditions
Myopia management using contrast management spectacle lenses
Eye Diseases
Registration Number
ISRCTN16801917
Lead Sponsor
SightGlass Vision
Brief Summary

2023 Abstract results in https://iovs.arvojournals.org/article.aspx?articleid=2788812 (added 16/02/2024)

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
10
Inclusion Criteria

1. Has had a self-reported oculo-visual examination in the last two years
2. Is at least 18 years of age and has full legal capacity to volunteer
3. Has read and understood the informed consent letter
4. Is willing and able to follow instructions and maintain the appointment schedule
5. Is correctable to a visual acuity of 20/40 or better (in each eye) with their habitual vision correction or 20/20 best-corrected
6. Is willing and able to wear contact lenses in the office for testing
7. Spectacle cylinder less than -0.75DC
8. Has clear corneas and no active ocular disease
9. Can tolerate having one eye covered and study procedures

Exclusion Criteria

1. Has any systemic disease affecting their ocular health
2. Is using any systemic or topical medications that will affect their ocular health
3. Has any ocular pathology or severe insufficiency of lacrimal secretion (moderate to severe dry eyes) that would affect clear vision when wearing spectacle lenses
4. Is aphakic

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Contrast sensitivity measured using the FrACT test at a 4m distance at 8, 12, 6 and 3 cycles per degree under photopic (85cd/m2) conditions with each spectacle lens at one timepoint
Secondary Outcome Measures
NameTimeMethod
Visual acuities measured using a standard letter chart at a 4m distance under photopic (85cd/m2) conditions with each spectacle lens at one timepoint
© Copyright 2025. All Rights Reserved by MedPath